Lalwani Nikhil sells ANIP shares
- Sold 5,400 shares on 10/15/2026
- Average price: $71.89
- Owns 333,689 shares after sale
Nikhil Lalwani, reporting
ANIP
ANI PHARMACEUTICALS INC SEC filings
Every EDGAR filing for ANI PHARMACEUTICALS INC (ANIP), newest first, with AI summaries and stories.
- Ticker
- ANIP
- CIK
- 1023024
- Latest filing
- 2d
Next: earnings expected ~Nov 9 · 10-Q expected ~Nov 9 (deadline Nov 9)
Insider activity
No open-market insider buys in the last 30 days.
Also: 3 open-market sales ($633K).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE ANI PHARMACEUTICALS, INC. shares sold by Lalwani Nikhil
- 5,400 shares to be sold
- Aggregate market value: $378,864
- Acquired via restricted stock awards on 02/28/2026
Nikhil Lalwani, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Cook Meredith sold shares on 2026-10-13
- Sold 500 shares at $73.59
- Total shares owned: 73,424
- Sale under Rule 10b5-1 plan
Meredith Cook, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, insider filing for ANIP
Stephen P. Carey, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Nikhil Lalwani, insider filing for ANIP
Nikhil Lalwani, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE 2 insider filings
Meredith Cook, insider filing for ANIP
Show all 2
- 4Insider filing for ANIP
- 4Insider filing for ANIP
Meredith Cook, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Nikhil Lalwani, planned sale of ANIP shares
Nikhil Lalwani, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Jeanne Thoma, planned sale of ANIP shares
Jeanne Thoma, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, insider filing for ANIP
Stephen P. Carey, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE 2 insider filings
Henry O Gosebruch, insider filing for ANIP
Show all 2
- 4Insider filing for ANIP
- 3New insider at ANIP
Henry O Gosebruch, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Nikhil Lalwani, insider filing for ANIP
Nikhil Lalwani, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Nikhil Lalwani, planned sale of ANIP shares
Nikhil Lalwani, reporting
ROUTINE8-KANI PHARMACEUTICALS INCANIPLIVE ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Meredith Cook, insider filing for ANIP
Meredith Cook, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Ori Gutwerg, insider filing for ANIP
Ori Gutwerg, reporting
NOTABLE10-QANI PHARMACEUTICALS INCANIPLIVE ROUTINE8-KANI PHARMACEUTICALS INCANIPLIVE ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, insider filing for ANIP
Stephen P. Carey, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, planned sale of ANIP shares
Stephen P. Carey, reporting
ROUTINESCHEDULE 13G/AANI PHARMACEUTICALS INCANIPLIVE Ownership stake disclosure by BlackRock, Inc. (amended)
BlackRock, Inc., filed by
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Meredith Cook, insider filing for ANIP
Meredith Cook, reporting
ROUTINES-8ANI PHARMACEUTICALS INCANIPLIVE ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Meredith Cook, insider filing for ANIP
Meredith Cook, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Patrick D Walsh, planned sale of ANIP shares
Patrick D Walsh, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, insider filing for ANIP
Stephen P. Carey, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, insider filing for ANIP
Stephen P. Carey, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Meredith Cook, insider filing for ANIP
Meredith Cook, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE 5 insider filings
Jeanne Thoma, insider filing for ANIP
Show all 5
- 4Insider filing for ANIP
- 4Insider filing for ANIP
- 4Insider filing for ANIP
- 4Insider filing for ANIP
- 4Insider filing for ANIP
Jeanne Thoma, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, insider filing for ANIP
Stephen P. Carey, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Thomas Haughey, planned sale of ANIP shares
Thomas Haughey, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Stephen P. Carey, planned sale of ANIP shares
Stephen P. Carey, reporting
ROUTINE8-KANI PHARMACEUTICALS INCANIPLIVE ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Patrick D Walsh, insider filing for ANIP
Patrick D Walsh, reporting
ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE 4 insider filings
Thomas Andrew Rowland, insider filing for ANIP
Show all 4
- 4Insider filing for ANIP
- 4Insider filing for ANIP
- 4Insider filing for ANIP
- 4Insider filing for ANIP
Thomas Andrew Rowland, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Patrick D Walsh, planned sale of ANIP shares
Patrick D Walsh, reporting
ROUTINE8-KANI PHARMACEUTICALS INCANIPLIVE ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Nikhil Lalwani, planned sale of ANIP shares
Nikhil Lalwani, reporting
ROUTINE144ANI PHARMACEUTICALS INCANIPLIVE Patrick D Walsh, planned sale of ANIP shares
Patrick D Walsh, reporting
NOTABLE10-QANI PHARMACEUTICALS INCANIPLIVE ROUTINE8-KANI PHARMACEUTICALS INCANIPLIVE ROUTINE4ANI PHARMACEUTICALS INCANIPLIVE Meredith Cook, insider filing for ANIP
Meredith Cook, reporting